Dr George Follows speaks with ecancertv at BSH 2016 about the UK CLL session he chaired, reviewing the data presented, the background, and potential clinical applications of current research.

Looking forward to patient impacts, he describes drugs currently moving through trial phases and approaching wider release.

For an introduction to the tumour microenvironment, you can view more from Dr Follows here.

For more from Dr Jan Burger, you can watch his interview with ecancertv here.

For more from Dr Stephen Mulligan, you can watch his interview with ecancertv here.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.